Preventing pneumococcal disease in the elderly: recent advances in vaccines and implications for clinical practice.
about
Revised adult immunization guideline recommended by the korean society of infectious diseases, 2014.Randomized controlled study of the safety and immunogenicity of pneumococcal vaccine formulations containing PhtD and detoxified pneumolysin with alum or adjuvant system AS02V in elderly adultsNasopharyngeal Carriage of Streptococcus Pneumoniae and Serotypes Indentified among Nursing Home Residents in Comparison to the Elderly and Patients Younger than 65 Years Living in Domestic EnvironmentThe management of community-acquired pneumonia in the elderlyRisk factors for death from invasive pneumococcal disease, Europe, 2010.Immunogenicity and Safety of the 13-Valent Pneumococcal Conjugate Vaccine versus the 23-Valent Polysaccharide Vaccine in Unvaccinated HIV-Infected Adults: A Pilot, Prospective Controlled Study.Is 13-Valent Pneumococcal Conjugate Vaccine (PCV13) Combined With 23-Valent Pneumococcal Polysaccharide Vaccine (PPSV23) Superior to PPSV23 Alone for Reducing Incidence or Severity of Pneumonia in Older Adults? A Clin-IQProteomic variation and diversity in clinical Streptococcus pneumoniae isolates from invasive and non-invasive sitesThe prevention of pneumococcal infectionsQuantitative and Functional Antibody Responses to the 13-Valent Conjugate and/or 23-Valent Purified Polysaccharide Vaccine in Aging HIV-Infected Adults.Theory and strategy for Pneumococcal vaccines in the elderly.Vaccination against infectious diseases: what is promising?Age-related immune response to pneumococcal polysaccharide vaccination: lessons for the clinic.Pneumonia and Streptococcus pneumoniae vaccine.Perspectives on vaccination in adults.Vaccination coverage and associated factors for receipt of the 23-valent pneumococcal polysaccharide vaccine in Taiwan: A nation-wide community-based study.Evaluating clinical effectiveness of 13-valent pneumococcal conjugate vaccination against pneumonia among middle-aged and older adults in Catalonia: results from the EPIVAC cohort study.Cost-effectiveness analysis of 13-valent pneumococcal conjugate vaccine versus 23-valent pneumococcal polysaccharide vaccine in an adult population in South Korea
P2860
Q26821898-8FDEBAC9-AD14-4BB3-9E2E-3913A3FD9E96Q33601853-297C4C00-B003-48CF-9304-6FF0D1D96C8BQ33891736-F2B28CC8-CD3D-45C6-ACC7-5C7DE99CAE83Q33915736-676FACD4-40EF-4DEF-B2FA-64767F38B15CQ35130282-7B5112F5-5F2C-4B44-8F24-ADE14E2E5963Q36040140-0AF12F7A-3872-453E-B2DE-E08238FA7DBBQ36067387-28706202-9957-453B-BA30-588F149201E8Q36390923-C9D11765-CCAE-4D6D-9349-6661DDA3297BQ36547952-52860364-D744-497E-A671-A052A826BF44Q36873030-6C8C1275-7D97-4B91-B24B-69419AAC7F43Q37309215-75F52B46-3327-4F98-B7C1-8EA7129D3001Q38234231-D2135FEF-8699-4705-BF1A-D852260B58E7Q38255618-E445AD11-4328-49C9-94A7-EA420AF59F65Q39452604-FDD23FA5-0AF7-49B2-AEF9-7B69FF291767Q43497830-2C01275B-5C38-4544-AA55-D746CB0FEFEBQ47547830-67A1F6A2-7498-4324-B541-00FAF575BC46Q54994810-845F4945-E8C7-4E61-9FD4-CFA48A1EBB69Q57211903-ADAB0D09-416F-4FCB-AA18-1C9C0D912728
P2860
Preventing pneumococcal disease in the elderly: recent advances in vaccines and implications for clinical practice.
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Preventing pneumococcal diseas ...... cations for clinical practice.
@en
type
label
Preventing pneumococcal diseas ...... cations for clinical practice.
@en
prefLabel
Preventing pneumococcal diseas ...... cations for clinical practice.
@en
P2860
P1433
P1476
Preventing pneumococcal diseas ...... ications for clinical practice
@en
P2093
Angel Vila-Corcoles
Olga Ochoa-Gondar
P2860
P2888
P304
P356
10.1007/S40266-013-0060-5
P577
2013-05-01T00:00:00Z